Mesenchymoma
A mixed mesenchymal tumor composed of two or more mesodermal cellular elements not commonly associated, not counting fibrous tissue as one of the elements. Mesenchymomas are widely distributed in the body and about 75% are malignant. (Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
Also Known As:
Mesenchymomas
Networked: 17
relevant articles (0 outcomes,
2 trials/studies)
Disease Context: Research Results
Related Diseases
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Mesenchymoma:
1. | Carbon MonoxideIBA
|
2. | HormonesIBA
|
3. | Malignant mesenchymal tumorIBA
|
4. | Gonadal Steroid Hormones (Sex Hormones)IBA
|
5. | Phenytoin (Dilantin)FDA LinkGeneric
|
6. | MethylcholanthreneIBA
|
7. | FibrinIBA
12/01/1975
- " Thirty-two children with solid tumors (lymphangioma, fibrosarcoma, hepatocarcinoma, osteogenic sarcoma, rhabdomyosarcoma, lymphosarcoma, mesenchymoma, hepatoma, Ewing's sarcoma, reticulum cell sarcoma, neuroblastoma, Hodgkin's disease, and brain tumors) were studied for alterations in coagulation by means of platelet counts, platelet aggregation, thrombelastogram, procoagulant and antigenic factor VIII, fibrin split products, and antithrombin III level. "
|
8. | Factor VIII (Coagulation Factor VIII)IBA
12/01/1975
- " Thirty-two children with solid tumors (lymphangioma, fibrosarcoma, hepatocarcinoma, osteogenic sarcoma, rhabdomyosarcoma, lymphosarcoma, mesenchymoma, hepatoma, Ewing's sarcoma, reticulum cell sarcoma, neuroblastoma, Hodgkin's disease, and brain tumors) were studied for alterations in coagulation by means of platelet counts, platelet aggregation, thrombelastogram, procoagulant and antigenic factor VIII, fibrin split products, and antithrombin III level. "
|
9. | Antithrombin IIIIBA
12/01/1975
- " Thirty-two children with solid tumors (lymphangioma, fibrosarcoma, hepatocarcinoma, osteogenic sarcoma, rhabdomyosarcoma, lymphosarcoma, mesenchymoma, hepatoma, Ewing's sarcoma, reticulum cell sarcoma, neuroblastoma, Hodgkin's disease, and brain tumors) were studied for alterations in coagulation by means of platelet counts, platelet aggregation, thrombelastogram, procoagulant and antigenic factor VIII, fibrin split products, and antithrombin III level. "
|
10. | AntibodiesIBA
|
|
Therapies and Procedures